ACAI Stock Overview
Safeplus International Holdings Limited develops and markets various technologies for the medical device industries.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Safeplus International Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.00013 |
| 52 Week High | US$0.11 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -99.89% |
| 3 Year Change | -99.99% |
| 5 Year Change | -99.97% |
| Change since IPO | -99.99% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| ACAI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 0.007% | 0.7% |
| 1Y | -99.9% | -1.0% | 23.9% |
Return vs Industry: ACAI underperformed the US Medical Equipment industry which returned 9.9% over the past year.
Return vs Market: ACAI underperformed the US Market which returned 24.4% over the past year.
Price Volatility
| ACAI volatility | |
|---|---|
| ACAI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ACAI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ACAI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1963 | n/a | n/a | www.biophan.com |
Safeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020.
Safeplus International Holdings Limited Fundamentals Summary
| ACAI fundamental statistics | |
|---|---|
| Market cap | US$673.00 |
| Earnings (TTM) | -US$7.54m |
| Revenue (TTM) | US$677.93k |
0.0x
P/S Ratio0.0x
P/E RatioIs ACAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACAI income statement (TTM) | |
|---|---|
| Revenue | US$677.93k |
| Cost of Revenue | US$1.01m |
| Gross Profit | -US$332.44k |
| Other Expenses | US$7.21m |
| Earnings | -US$7.54m |
Last Reported Earnings
Feb 28, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did ACAI perform over the long term?
See historical performance and comparison